Advertisement
Canada markets open in 1 hour 35 minutes
  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CAD/USD

    0.7261
    +0.0000 (+0.00%)
     
  • CRUDE OIL

    80.60
    -1.33 (-1.62%)
     
  • Bitcoin CAD

    79,561.30
    -4,800.06 (-5.69%)
     
  • CMC Crypto 200

    1,236.69
    -102.38 (-7.64%)
     
  • GOLD FUTURES

    2,305.00
    +2.10 (+0.09%)
     
  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • NASDAQ futures

    17,457.50
    -113.75 (-0.65%)
     
  • VOLATILITY

    16.14
    +0.49 (+3.13%)
     
  • FTSE

    8,152.23
    +8.10 (+0.10%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • CAD/EUR

    0.6802
    0.0000 (0.00%)
     

Those who invested in Acadia Healthcare Company (NASDAQ:ACHC) five years ago are up 167%

It hasn't been the best quarter for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shareholders, since the share price has fallen 10% in that time. But that doesn't change the fact that shareholders have received really good returns over the last five years. In fact, the share price is 167% higher today. To some, the recent pullback wouldn't be surprising after such a fast rise. Only time will tell if there is still too much optimism currently reflected in the share price.

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

Check out our latest analysis for Acadia Healthcare Company

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

ADVERTISEMENT

During five years of share price growth, Acadia Healthcare Company achieved compound earnings per share (EPS) growth of 41% per year. We do note that extraordinary items have impacted its earnings history. The EPS growth is more impressive than the yearly share price gain of 22% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

A Different Perspective

Acadia Healthcare Company shareholders gained a total return of 2.2% during the year. Unfortunately this falls short of the market return. If we look back over five years, the returns are even better, coming in at 22% per year for five years. Maybe the share price is just taking a breather while the business executes on its growth strategy. It's always interesting to track share price performance over the longer term. But to understand Acadia Healthcare Company better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Acadia Healthcare Company you should know about.

We will like Acadia Healthcare Company better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.